Literature DB >> 2742729

The effects of d-amphetamine on arousal, cognition, and mood after prolonged total sleep deprivation.

P A Newhouse1, G Belenky, M Thomas, D Thorne, H C Sing, J Fertig.   

Abstract

Thirty-six normal male subjects underwent total sleep deprivation for 48 hours, were then administered either placebo, 5, 10, or 20 mg of d-amphetamine, and sleep deprived for an additional 12 hours. Sleep deprivation produced a significant reduction in sleep latency, as well as marked decrements in cognitive performance and self-ratings reflecting vigor and fatigue. Amphetamine reversed these effects in a dose-related way but the pattern and persistence of the reversal varied across measures. After 20 mg, sleep latency normalized for several hours, but then declined. Behavioral effects tended to follow the pattern of sleep latency. On cognitive tasks, 20 mg produced a sustained return to normal performance in an attentional arithmetic task and a gradual improvement in a verbal reasoning task. The partial temporal dissociation among sleep latency, behavioral, and cognitive effects suggests that varying doses of amphetamine may have time-related differential neurochemical effects or that various dimensions of arousal and alertness may be differentially sensitive to amphetamine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2742729     DOI: 10.1016/0893-133x(89)90018-3

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  9 in total

1.  Orienting and alerting: effect of 24 h of prolonged wakefulness.

Authors:  Maria Casagrande; Diana Martella; Enrico Di Pace; Fabio Pirri; Francesco Guadalupi
Journal:  Exp Brain Res       Date:  2005-11-25       Impact factor: 1.972

2.  Performance on the continuous performance test in children with ADHD is associated with sleep efficiency.

Authors:  Reut Gruber; Natalie Grizenko; George Schwartz; Johanne Bellingham; Rosherrie Guzman; Ridha Joober
Journal:  Sleep       Date:  2007-08       Impact factor: 5.849

Review 3.  Approaches to measuring the effects of wake-promoting drugs: a focus on cognitive function.

Authors:  Christopher J Edgar; Edward F Pace-Schott; Keith A Wesnes
Journal:  Hum Psychopharmacol       Date:  2009-07       Impact factor: 1.672

4.  Caffeine reversal of sleep deprivation effects on alertness and mood.

Authors:  D Penetar; U McCann; D Thorne; G Kamimori; C Galinski; H Sing; M Thomas; G Belenky
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study.

Authors:  Sarah A Morrow; Audrey Smerbeck; Kara Patrick; Diane Cookfair; Bianca Weinstock-Guttman; Ralph H B Benedict
Journal:  J Neurol       Date:  2012-09-23       Impact factor: 4.849

6.  Sleep deprivation differentially impairs cognitive performance in abstinent methylenedioxymethamphetamine ("Ecstasy") users.

Authors:  Una D McCann; Michael J Wilson; Francis P Sgambati; George A Ricaurte
Journal:  J Neurosci       Date:  2009-11-04       Impact factor: 6.167

7.  Effects of dexamphetamine with and without alcohol on simulated driving.

Authors:  Ries Simons; Marieke Martens; Jan Ramaekers; Arno Krul; Ineke Klöpping-Ketelaars; Gisela Skopp
Journal:  Psychopharmacology (Berl)       Date:  2011-11-11       Impact factor: 4.530

8.  Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects.

Authors:  Friederike Holze; Patrick Vizeli; Felix Müller; Laura Ley; Raoul Duerig; Nimmy Varghese; Anne Eckert; Stefan Borgwardt; Matthias E Liechti
Journal:  Neuropsychopharmacology       Date:  2019-11-16       Impact factor: 7.853

Review 9.  Predicting and mitigating fatigue effects due to sleep deprivation: A review.

Authors:  Kylie C Kayser; Vannia A Puig; Justin R Estepp
Journal:  Front Neurosci       Date:  2022-08-05       Impact factor: 5.152

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.